Evolent Health Inc. (NYSE:EVH)’s share price fell 3% during mid-day trading on Friday . The stock traded as low as $25.86 and last traded at $25.90, with a volume of 297,197 shares changing hands. The stock had previously closed at $26.69.

Several research firms have weighed in on EVH. FBR & Co reaffirmed a “buy” rating on shares of Evolent Health in a research note on Saturday, May 14th. Zacks Investment Research downgraded shares of Evolent Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 4th. Canaccord Genuity reissued a “buy” rating and set a $30.00 target price on shares of Evolent Health in a research report on Sunday, August 7th. Jefferies Group started coverage on shares of Evolent Health in a research report on Tuesday, July 26th. They set a “buy” rating and a $28.00 target price for the company. Finally, Leerink Swann reissued an “outperform” rating and set a $20.00 target price on shares of Evolent Health in a research report on Sunday, July 17th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $22.50.

The stock’s market cap is $1.56 billion. The firm has a 50-day moving average of $22.29 and a 200-day moving average of $14.47.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.16) by $0.04. The firm had revenue of $56.50 million for the quarter, compared to analysts’ expectations of $51.96 million. During the same period in the previous year, the company earned ($0.95) EPS. The company’s quarterly revenue was up 443.3% on a year-over-year basis. On average, equities analysts predict that Evolent Health Inc. will post ($0.55) EPS for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group raised its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned 0.60% of Evolent Health worth $4,310,000 at the end of the most recent quarter.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.